AFLAC (NYSE:AFL) updated its FY 2020
Pre-Market earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 4.30-4.50 for the period, compared to the Thomson Reuters consensus estimate of $4.48. AFLAC also updated its FY20 guidance to $4.35-4.50 EPS.
Several analysts recently issued reports on the company. UBS Group increased their target price on AFLAC from $51.00 to $53.00 and gave the stock a neutral rating in a research report on Thursday, October 10th. Bank of America set a $55.00 target price on AFLAC and gave the company a hold rating in a research note on Friday, October 25th. Finally, Barclays lowered their price target on AFLAC from $53.00 to $49.00 and set an equal weight rating on the stock in a report on Friday, August 23rd. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus target price of $53.73.
Shares of AFL stock opened at $52.68 on Tuesday. The stock has a market cap of $40.25 billion, a P/E ratio of 12.66, a PEG ratio of 2.94 and a beta of 0.71. AFLAC has a 52 week low of $41.88 and a 52 week high of $57.18. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.21. The company’s fifty day simple moving average is $53.64 and its two-hundred day simple moving average is $53.13.
The company also recently declared a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Wednesday, November 20th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date was Tuesday, November 19th. AFLAC’s payout ratio is presently 25.96%.
In other AFLAC news, Director Toshihiko Fukuzawa sold 1,500 shares of AFLAC stock in a transaction on Friday, September 27th. The shares were sold at an average price of $52.00, for a total value of $78,000.00. Following the completion of the transaction, the director now directly owns 11,349 shares of the company’s stock, valued at approximately $590,148. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Karole Lloyd bought 1,000 shares of AFLAC stock in a transaction dated Thursday, November 7th. The stock was acquired at an average price of $54.08 per share, for a total transaction of $54,080.00. Following the completion of the acquisition, the director now owns 28,181 shares in the company, valued at $1,524,028.48. The disclosure for this purchase can be found here. Company insiders own 1.30% of the company’s stock.
Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Featured Article: How is the Producer Price Index calculated?
Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.